Prediction of malignant hyperthermia susceptibility by clinical signs.
D000293:Adolescent; D000768:Anesthesia, General / Q000009:adverse effects*; D001706:Biopsy; D002110:Caffeine / Q000494:pharmacology; D002648:Child; D006221:Halothane / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008305:Malignant Hyperthermia / Q000517:prevention & control*; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000473:pathology; D012189:Retrospective Studies; D013390:Succinylcholine; D013398:Sudden Infant Death / Q000235:genetics
D002110:Caffeine; D013390:Succinylcholine; D006221:Halothane